A recent study has proposed a novel mechanism whereby the high mobility group AT-hook 2 (HMG2A) transcript promotes non-small cell lung cancer progression by competing with transforming growth factor β receptor III (Tgfbr3) for let-7 binding [26]. This evidence concerns the gene HMGB3 and non-small cell lung carcinoma.